Complement-fixing and complement-fixing inhibiting (CFI) 
With the development of the immunoelectrophoresis technique by Grabar (6) , subclasses of immunoglobulins (Ig) were identified in numerous animal species (17) . The early work of Benacerraf, et al. (2) demonstrated distinguishing biological and serological properties between guinea pig IgG, and IgG2 subclasses; the latter fixed complement, whereas the former mediated local anaphylaxis. The biological significance of immunoglobulin subclasses during the immune response to pathogenic microorganisms, however, remains unclarified.
We report here the finding of complement-fixing (CF) and complement-fixing inhibiting (CFI) virus-specific antibodies in rhesus monkeys experimentally infected with various simian poxviruses. The temporal appearances of these antibodies were studied in relationship to clinical and convalescent phases of the diseases. Additional serological properties of CF and CFI antibodies were studied by serum neutralization and passive hemagglutination tests. Ig classes were characterized by two-step radioimmunoelectrophoresis. The (18) from a spontaneous outbreak of disease in a colony of monkeys in Pennsylvania. The virus was obtained in 1961 and has been propagated in rhesus monkey kidney cells. Virus was added to monolayers of LLC-MK2 cells grown in roller bottles and allowed to adsorb for 2 h at 37 C. Medium 199 in Earle balanced salt solution with 2% fetal calf serum, antibiotics (penicillin, streptomycin, and mycostatin), and sodium bicarbonate (medium adjusted to pH 7.2) was added, and cells were incubated at 37 C until maximum cytopathic effect (CPE) was observed. A pool of cells and medium from several bottles was frozen and thawed three times, sonically treated for three 1-min intervals, and centrifuged at 5,000 X g for 10 min.
MATERIALS AND METHODS Viruses. Monkey poxvirus (MPV) was isolated by Prier in 1959
The Tanapox virus (5) Olsen and Yohn (15) . Minced tumor was homogenized in a Sorvall blender with equal volumes of sodium citratebuffered saline and fluorocarbon (Genetron 113, Racon Inc., Wichita, Kan.) to produce a 40% tumor homogenate. The fluorocarbon-saline mixture was centrifuged at 2,000 X g for 10 min, and the saline layer was decanted from the fluorocarbon. The saline extract was extracted twice more with fresh fluorocarbon and reduced in volume by dialysis against Aquacide III (Calbiochem, San Diego, Calif.). The dialyzed material was layered upon 36% sucrose and centrifuged in a Beckman L-2 Model 65B ultracentrifuge at 60,000 X g for 90 min to remove whole virus. After centrifugation, the saline layer above the sucrose was used as Yaba virus-associated, soluble (YS) antigens.
The virus pellet was resuspended in Veronal buffer (pH 7.4) and treated with an X-Press (Ab Biox-Nacka, Sweden) a total of 12 times at -70 C to disrupt the virions. Disrupted Yaba virus material was then thawed and centrifuged at 8,000 X g for 10 min. The supernatant fluid contained soluble virion (X) antigens previously referred to as YX antigen. The insoluble material also contained virion antigens but, because of the small quantity obtained, was not used in this study.
Two similar groups of antigens were prepared from monkey pox and Tanapox After an additional incubation for 30 min at 37 C, the plates were centrifuged at 800 X g for 1 min, and the test results were recorded. Fixation of complement was graded from 1+ to 4+. The CF antibody titer was expressed as the highest dilution of serum that gave a 3+ or greater complement-fixing reaction. The CFI test, as originally described by Rice (20) , was modified to the microtiter technique by Olsen and Yohn (16) . Twofold serial dilutions of test sera were incubated with 2 CFU of antigen for 16 to 24 h at 4 C. Two units of reference serum and 5 C'H60 units of guinea pig complement were added to the test, and incubation at 4 C was continued for an additional 24 h. Antibodysensitized sheep red blood cells were added, and the tests were incubated for 30 min at 37 C. The plates were centrifuged at 800 X g for 1 min, and the results were recorded using the same scoring as described above for the CF test. The CFI antibody titer was expressed as the highest dilution of test serum which blocked by greater than 50% the fixation of complement by reference antibody and antigen. In the CFI test, each test serum was concomitantly tested alone and with the reference antibody for anticomplementary activity. A positive control was used to show that the reference antibody and the antigen both fixed complement.
CFI reference antigens were titrated against a homologous reference serum by the block titration method. The various reference sera were: (i) monkey pox antiserum from rabbit no. 39 Monkey gamma globulin precipitin arcs were developed by goat anti-monkey gamma globulin serum and rabbit anti-monkey gamma globulin serum. The preparation of the monkey gamma globulin-specific goat and rabbit sera was according to the procedure of Olsen et al. (14) .
All unbound protein components were removed from the immunoelectropherograms by washing in PBS (pH 7.2) for 24 h. After thorough washing, 125I-labeled antigen was placed in the immunoelectropherogram troughs and allowed to diffuse against monkey-precipitated gamma globulins for 48 h. After the second immunodiffusion step, the immunoelectropherograms were extensively washed for 72 h in PBS and for an additional 24 h in distilled water before air-drying and staining with Buffalo blue-black stain.
Autoradiograms were made by placing Kodak X-ray film (Electron Images Plates) against the dried agar for an appropriate period of time. The X-ray film was developed by Kodak Liquidol developer.
RESULTS
Humoral antibody response in monkeys to MPV. In monkeys infected with MPV ( Fig. 1 ) CF antibodies were generally detectable by the first week postinfection (PI) and peak CF titers against both virus-associated MS and virion MX antigens were observed by day 9 PI. In nearly all six MPV-infected animals, peak CF titers corresponded to the period when the lesions were most prominent. As the lesions regressed, CF antibody titers decline, and in most monkeys such antibodies were not detectable after the 10th week PI. As illustrated in Fig. 1 , the CF response to MS and MX antigens were quite similar.
Virus-neutralizing antibodies (Fig. 1 ), although they appeared in the serum of MPV-infected animals at the same time as did CF antibody, did not disappear throughout the observation period (36 weeks).
CFI antibodies were first detected in MPVinfected monkeys to MS antigen ( Fig. 1) Characteristics of monkey CF and CFI antibody. Globulin from serum samples of monkey no. 215 that demonstrated CF (4 weeks PI) and CFI activity (24 weeks PI) with MS antigen were analyzed for antigen-binding activity in the RIE test (Fig. 2) . Both CF-and CFI-positive sera contained globulin with electrophoretic characteristics of IgG which bound 52I-labeled MS antigens. A preimmune serum sample, an early clinical phase serum, and a late convalescent serum of monkey no. 215 were tested for direct CF reactivity with MS antigen using guinea pig, rabbit, and monkey complement (Table 4) . Serum taken from monkey no. 215 during the acute phase of MPV infection (4 weeks PI) fixed all sources of complement. Convalescent serum from the same animal which had a CFI titer to MS antigen of 1:16 did nct fix heterologous (guinea pig, rabbit) or homologous (monkey) complement. In addition, only clinical-phase serum agglutinated MS-coated, tanned cells in the passive hemagglutination test (PHA) ( Table 4) . As mentioned earlier, both CF and CFI sera neutralized MPV at a dilution of 1:30. Although specific CFI antibodies have been detected in the avian (19) , equine (20) , feline (16) , and human (21) sera, we felt that it was first necessary to show serological specificity of the CFI test for monkey antibody. The possibilities that CFI-positive monkey sera nonspecifically blocked the reaction between reference antibody (CF anti-poxvirus serum) and poxvirus antigen and/or interfered with the fixing of complement were excluded when it was demonstrated that (i) CFI positive monkey serum had little or no effect on fixation of complement to reference poxvirus antigen-reference antibody complexes, and (ii) CFI-positive sera failed to block heterologous CF reactions. The demonstration that CFI titers were essentially inversely proportional to the units of viral antigen in the CFI test was further evidence that the activity in the monkey sera was directed toward the viral antigen.
The failure of the convalescent CFI positive sera to fix homologous (monkey) complement as The persistence of CF antibody in infected monkeys varied between the three diseases. The time of appearance aind disappearance of CF antibody in Tanapox-and MPV-infected animals was relatively short (approximately 10-12 weeks), whereas in Yaba-infected animals the CF antibody was detected up to 35 weeks PI. The presence of CF antibody in all three pox diseases appeared to depend on the presence of persistent viral antigen stimulation. The temporal relationship of CF and CFI antibody with respect to virus antigen stimulation has also been observed by McGuire et al. (11) in horses infected with infectious equine anemia virus.
The biological role of CF antibody during the clinical phase of the disease is clearly defined in most viral diseases. It is well accepted that CF antibody plays a major role in virus neutralization as well as in promoting antigen clearance by augmenting a general inflammatory response. Although little is known about the CF subclasses of IgG in viral pathogenesis, our studies and reports by others (11) suggest that the host possesses a regulatory mechanism for shutting down CF antibody following immunogenic stimulation. From an evolutionary point of view such a mechanism would have a positive selection value to the host in counteracting immunologic diseases associated with CF antibody-viral antigen complexes. Immune complex diseases are prevalent in chronic virus infections such as lymphocytic choriomeningitis virus infections in mice and the pathological affect of virus infection appears only to be moderated where the host is rendered tolerant (8), i.e., the host lacks virus-specific CF antibody but not nonCF fluorescent antibody.
It may be hypothesized, therefore, that the avoidance of immunologic disease due to autoantibodies or immune complexes is mediated by antigen-specific CFI antibody. The function of a CFI antibody may play a similar role as the noncytotoxic enhancing antibody described by Hellstrom et al. (7) in various tumor-bearing animals.
